Histopath - Resp Flashcards

1
Q

Asthma MACRO & MICROscopic features

A

MACRO:

  • mucous plug
  • overinflated lungs

MICRO:

  • hyperaemia
  • eosinophilic inflammation
  • goblet cell hyperplasia
  • hypertrophic constricted muscle
  • mucus plugging
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

COPD - Chronic Bronchitis - MACRO & MICRO scopic features

A

MACRO:
- airway dilation

MICRO:

  • mucous gland hypertrophy
  • goblet cell hyperplasia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Smoking related emphysema - pattern

A
  • centered around airways

- centrilobular

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Alpha 1 anti trypsin related emphysema - pattern

A
  • diffuse loss of alveolae

- panacinar

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

CT evidence of bronchiectasis

A

Bronchial wall thickening

Positive signet ring sign

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Most common causative organism of Bronchiectasis

A

Staph aureus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Organism associated with longstanding bronchiectasis

A

Pseudomonas

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Pulmonary Oedema Progression of MACRO & MICRO scopic changes

A

Acute:

  • MACRO = heavy watery lungs
  • MICRO = intra-alveolar fluid

Chronic:
- MICRO = iron laden macrophages, fibrosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Diffuse alveolar damage - types?

A

Adults = acute respiratory distress syndrome

Neonates = hyaline membrane disease of newborn / surfactant deficiency / respiratory distress syndrome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

ARDS - MACRO & MICRO scopic features

A

MACRO:

  • firm, plum coloured expanded lungs
  • airless
  • often >1kg

MICRO

  • capillary congestion
  • fluid leakage (in exudative phase)
  • dead cells + proteinaceous debris
  • thick bands of protein deposited on alveolar epithelium ‘hyaline membranes’
  • exudates organise into scar/granulation tissue
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

ARDS on CXR

A

White out of all lung fields

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Bronchopneumonia - features

A
  • low virulence organisms in compromised host
  • Staph, Haemophilus, Strep, Pneumococcus
  • patchy bronchial + peribronchial distribution
  • often lower lobes
  • neutrophils + inflammatory exudate
  • mainly around airways then spreads into alveolar spaces
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Lobar pneumonia - features

A
  • high virulence organisms
  • 90-95% Pneumococci e.g. S. pneumoniae
  • congestion –> red hepatisation –> grey hepatisation –> resolution
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Stages of of red hepatisation process

A

Acute inflammation
Capillary leakage
Contents leaks into alveoli

Appearance:

  • Hyperaemia
  • Intra-alveolar neutrophils
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Causative organism of abscess formation (pneumonia)

A

Klebsiella

in EtOH dependent patients

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Idiopathic pulmonary fibrosis macroscopic features

A

Basal + peripheral fibrosis

Cyst formation

17
Q

Presentation of small emboli

A

Pleuritic chest pain

Acute SOB +/- chronic progressive SOB

18
Q

Presentation of large emboli

A

Sudden death

Acute R heart failure

CVS shock

If patient survives, 30% develop more

19
Q

Risk of Bevacizumab in lung ca.?

A

Some patients develop fatal lung haemorrhage

Invasive squamous cell carcinoma type

20
Q

Most common type of ca. seen in non-smokers?

A

Adenocarcinoma

21
Q

Rank lung ca. by prognosis

A

Terrible = small cell carcinoma

Poor = large cell carcinoma

Extrathoracic mets common + early = Adenocarcinoma

Local spread, late mets = Invasive squamous cell carcinoma

22
Q

Type of cancer associated with paraneoplastic syndromes

A

Small cell carcinoma